MarketsandMarkets forecasts the global food as medicine market will grow from USD 254.15 billion in 2026 to USD 400.81 billion by 2031 at a 9.5% CAGR. The related probiotic supplements market is projected to increase from USD 10.60 billion to USD 16.69 billion over the same period, also at a 9.5% CAGR, according to a report issued Aug. 25, 2026. Growth across both sectors is being driven by rising awareness of nutrition, digestive and microbiome health, chronic disease prevention, functional nutrition, personalized healthcare and demand for science-backed wellness products. Functional foods are expected to lead the food as medicine market by product type, with gastrointestinal health the largest function segment, while capsules, digestive health, adults and Lactobacilli are projected to lead the probiotic supplements market by product form, application, end user and ingredient, respectively. Asia Pacific is expected to be the fastest-growing region for both markets, supported by rising healthcare awareness, disposable incomes, urbanization, chronic disease prevalence, changing dietary habits, e-commerce and demand for preventive and personalized nutrition. Key innovation areas include nutrigenomics, microbiomics, precision nutrition, probiotics, prebiotics, synbiotics, clinically supported strains, advanced delivery technologies and bioactive ingredients.